A recent study has tiger conservationists gearing up for a new battle to protect vital forest links from development.

Terming the USFDA ban on its Toansa plant 'disappointing', Ranbaxy Laboaratories today said it will take 'appropriate management action' fo...

Analysts at top brokerage firms have turned cautious on Ranbaxy after reports that the FDA has issued an import alert on the Mohali unit.

US authorities seized drugs made by Sun Pharmaceuticals’ US subsidiary for violation of manufacturing standards, pushing down share prices ...

Recent warning letters issued by US Food and Drug Administration, to manufacturing units of Indian pharmaceutical companies, have significa...

Foreign brokerages have downgraded Ranbaxy Laboratories after the US FDA (Food and Drug Administration) recently invoked its Application In...

Shares of domestic pharma major Ranbaxy Laboratories today touched a 52-week low of Rs 250.50 with analysts saying that it is the effect of...

Ranbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated markets.

maker Ranbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated markets.

India’s largest drug maker Ranbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated mar...

The company is expected to invest a “couple of hundred crores” in the high capacity plant that will be developed in two phases, a Ranbaxy i...

US drug makers are accusing India of being a source of low-quality exports & are exerting pressure on USFDA.